These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 20477206)
1. Potential of imatinib mesylate as a novel treatment for pulmonary fibrosis. Chhina M; Shlobin OA; Grant G; Nathan SD Expert Rev Respir Med; 2008 Aug; 2(4):419-31. PubMed ID: 20477206 [TBL] [Abstract][Full Text] [Related]
2. Idiopathic pulmonary fibrosis: current trends in management. Raghu G; Chang J Clin Chest Med; 2004 Dec; 25(4):621-36, v. PubMed ID: 15564012 [TBL] [Abstract][Full Text] [Related]
3. Colchicine, cyclophosphamide and prednisone in the treatment of mild-moderate idiopathic pulmonary fibrosis: comparison of three currently available therapeutic regimens. Fiorucci E; Lucantoni G; Paone G; Zotti M; Li BE; Serpilli M; Regimenti P; Cammarella I; Puglisi G; Schmid G Eur Rev Med Pharmacol Sci; 2008; 12(2):105-11. PubMed ID: 18575160 [TBL] [Abstract][Full Text] [Related]
4. Treatment of idiopathic pulmonary fibrosis: is there anything new? Abdelaziz MM; Samman YS; Wali SO; Hamad MM Respirology; 2005 Jun; 10(3):284-9. PubMed ID: 15955138 [TBL] [Abstract][Full Text] [Related]
5. [Idiopathic pulmonary fibrosis; description of a Dutch cohort]. Barlo NP; van Moorsel CH; van den Bosch JM; van de Graaf EA; Kwakkel-van Erp JM; Grutters JC Ned Tijdschr Geneeskd; 2009; 153():B425. PubMed ID: 19785823 [TBL] [Abstract][Full Text] [Related]
6. New developments in the therapy of pulmonary fibrosis. Scriabine A; Rabin DU Adv Pharmacol; 2009; 57():419-64. PubMed ID: 20230768 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of bosentan for idiopathic pulmonary fibrosis. Swigris JJ; Brown KK Expert Rev Respir Med; 2008 Jun; 2(3):315-21. PubMed ID: 20477195 [TBL] [Abstract][Full Text] [Related]